TNFRSF8 and acute lymphoblastic leukemia: It is shown that 80% of indications of disease were blood and bone marrow cancers, including multiple myeloma, large cell lymphoma, Philadelphia chromosome-negative acute lymphoblastic leukemia, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), CD30-positive Hodgkin lymphoma, follicular lymphoma, large B-cell lymphoma, and chronic lymphocytic leukemia (CLL), followed by thyroid cancer (6.7%), which included medullary thyroid cancer.